The Makers of Doan's(R) Respond to the FTC's Ruling on Its Advertising
SUMMIT, N.J., March 12 /PRNewswire/ -- The makers of Doan's have issued the following statement: The makers of Doan's backache medication strongly disagree with the ruling by the administrative law judge of the Federal Trade Commission. Doan's has been an effective backache remedy for over 50 years. In fact, the U.S. Food and Drug Administration's rules state that the active ingredient in Doan's is effective for backache relief and permits Doan's labeling to make that claim. Based on these FDA rules, Doan's advertising has stated that it is effective for relieving backache pain and that it contains an active ingredient, magnesium salicylate, that other leading analgesics do not. These two statements are true and unchallenged by the FTC. The U.S. FDA would not allow us to claim that Doan's relieves backache pain if it did not work. Millions of consumers would not continue to buy the product if it did not relieve their backache pain. Contrary to the FTC's interpretation, Doan's advertising has never stated that it is more effective than other leading analgesic pain relievers. To date, millions of consumers have chosen Doan's because it works. Their continued support speaks volumes regarding its effectiveness. Doan's is available in three formulas: regular strength, extra strength and extra strength nighttime caplets.RELATED LINKS
SOURCE Novartis Consumer Health, Inc.